RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from New Scientist
Explore the latest news, articles and features
Mind
The relationship recession is even bigger for Gen Z than we thought
News
Technology
Killer robots are here – we must finally decide whether to accept them
Leader
Technology
Quantum computer quickly mines cryptocurrency while using less energy
News
Mind
How to sparkle in conversation with strangers
Comment
Popular articles
Trending New Scientist articles
1
Fully autonomous drones have killed human soldiers for the first time
2
How to sparkle in conversation with strangers
3
The relationship recession is even bigger for Gen Z than we thought
4
Unpicking endometriosis reveals how it affects more than the pelvis
5
Why we should all take quantum physics extremely personally
6
Does gravity create reality? A shocking path to a theory of everything
7
Explore the mind-bending and paradoxical art of M C. Escher
8
Earliest use of anaesthetics uncovered in Chinese doctor’s tomb
9
10,000 new planets found hidden in NASA telescope data
10
The 14 best science and tech documentaries of 2025 so far
